[go: up one dir, main page]

DE60030141D1 - Isolierte mhc-klasse ii-bindende peptide, und deren verwendung - Google Patents

Isolierte mhc-klasse ii-bindende peptide, und deren verwendung

Info

Publication number
DE60030141D1
DE60030141D1 DE60030141T DE60030141T DE60030141D1 DE 60030141 D1 DE60030141 D1 DE 60030141D1 DE 60030141 T DE60030141 T DE 60030141T DE 60030141 T DE60030141 T DE 60030141T DE 60030141 D1 DE60030141 D1 DE 60030141D1
Authority
DE
Germany
Prior art keywords
mhc class
binding peptides
isolated mhc
peptides
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60030141T
Other languages
English (en)
Other versions
DE60030141T2 (de
Inventor
Ozlem Tureci
Ugur Sahin
Michael Pfreundschuh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research Ltd
Ludwig Cancer Research
Original Assignee
Ludwig Institute for Cancer Research Ltd
Ludwig Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Institute for Cancer Research Ltd, Ludwig Cancer Research filed Critical Ludwig Institute for Cancer Research Ltd
Application granted granted Critical
Publication of DE60030141D1 publication Critical patent/DE60030141D1/de
Publication of DE60030141T2 publication Critical patent/DE60030141T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60030141T 1999-09-29 2000-09-26 Isolierte mhc-klasse ii-bindende peptide, und deren verwendung Expired - Lifetime DE60030141T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/408,036 US6800730B1 (en) 1998-10-02 1999-09-29 Isolated peptides which bind to MHC class II molecules, and uses thereof
PCT/US2000/026411 WO2001023560A2 (en) 1999-09-29 2000-09-26 Isolated peptides which bind to mhc class ii molecules, and uses thereof
US408036 2009-03-20

Publications (2)

Publication Number Publication Date
DE60030141D1 true DE60030141D1 (de) 2006-09-28
DE60030141T2 DE60030141T2 (de) 2007-08-09

Family

ID=23614589

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60030141T Expired - Lifetime DE60030141T2 (de) 1999-09-29 2000-09-26 Isolierte mhc-klasse ii-bindende peptide, und deren verwendung

Country Status (6)

Country Link
US (2) US6800730B1 (de)
EP (1) EP1220908B1 (de)
AT (1) ATE336579T1 (de)
AU (1) AU7615900A (de)
DE (1) DE60030141T2 (de)
WO (1) WO2001023560A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2398743C (en) * 2000-01-28 2015-06-23 The Government Of The United States Of America Novel mhc class ii restricted t cell epitopes from the cancer antigen, ny eso-1
US8637305B2 (en) * 2001-11-07 2014-01-28 Mannkind Corporation Expression vectors encoding epitopes of target-associated antigens and methods for their design
WO2005000870A2 (en) * 2003-05-30 2005-01-06 Ludwig Institute Of Cancer Research Isolated ny-eso-1 peptides which bind to hla class ii molecules and uses thereof
WO2005010190A1 (en) * 2003-07-22 2005-02-03 Ludwig Institute For Cancer Research Ssx-2 peptides presented by hla class ii molucules
US7632506B2 (en) * 2004-09-09 2009-12-15 Ludwig Institute For Cancer Research Identification of new NY-ESO-1 epitopes recognized by CD4+ T-cells
US20070232558A1 (en) * 2006-03-31 2007-10-04 Mcneel Douglas G Methods and compositions for treating prostate cancer using dna vaccines directed to cancer testis antigen
US7910565B2 (en) 2006-09-01 2011-03-22 Wisconsin Alumni Research Foundation Prostate cancer vaccine
US8309096B2 (en) * 2007-01-15 2012-11-13 Glaxosmithkline Biologicals S.A. Fusion protein
US20100183658A1 (en) * 2007-03-30 2010-07-22 The Brigham And Women's Hospital, Inc. Novel Compounds for Enhancing MHC Class II Therapies
CA2755734A1 (en) 2009-03-17 2010-09-23 Gaetan Otto Improved detection of gene expression
CA3071740C (en) * 2010-09-20 2020-09-08 Biontech Ag Antigen-specific t cell receptors and t cell epitopes

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804381A (en) * 1996-10-03 1998-09-08 Cornell Research Foundation Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof
US6723832B1 (en) * 1996-10-03 2004-04-20 Ludwig Institute For Cancer Research Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof
JP3782100B2 (ja) * 1992-08-07 2006-06-07 エピミューン，インコーポレイティド Ｈｌａ結合性ペプチド及びその用途
AU698962B2 (en) * 1993-09-14 1998-11-12 Epimmune, Inc. Alteration of immune response using pan DR-binding peptides
US5824315A (en) * 1993-10-25 1998-10-20 Anergen, Inc. Binding affinity of antigenic peptides for MHC molecules
GB9414580D0 (en) * 1994-07-19 1994-09-07 Cancer Res Campaign Tech Materials and methods relating to the diagnosis of synovial sarcomas
US6251603B1 (en) * 1996-10-03 2001-06-26 Ludwig Institute For Cancer Research Method for determining status of a cancerous condition by determining antibodies to NY-ESO-1 in a patient sample
US6413517B1 (en) * 1997-01-23 2002-07-02 Epimmune, Inc. Identification of broadly reactive DR restricted epitopes
US6287756B1 (en) * 1997-05-05 2001-09-11 Ludwig Institute For Cancer Research Methods for determining presence of cancer in a sample by determining expression of an SSX gene
US5965535A (en) * 1997-09-12 1999-10-12 Ludwig Institute For Cancer Research Mage-3 peptides presented by HLA class II molecules
AU9572098A (en) * 1997-10-08 1999-04-27 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Novel human cancer antigen ny eso-1/cag-3 and gene encoding same
AU3102299A (en) * 1998-03-20 1999-10-11 Genzyme Corporation Compositions and methods for gene-based vaccines to provoke T cell responses

Also Published As

Publication number Publication date
EP1220908B1 (de) 2006-08-16
WO2001023560A2 (en) 2001-04-05
US20040214284A1 (en) 2004-10-28
DE60030141T2 (de) 2007-08-09
US7385044B2 (en) 2008-06-10
US6800730B1 (en) 2004-10-05
ATE336579T1 (de) 2006-09-15
WO2001023560A3 (en) 2001-11-29
EP1220908A2 (de) 2002-07-10
AU7615900A (en) 2001-04-30

Similar Documents

Publication Publication Date Title
UA98295C2 (ru) Опухолево-ассоциированный пептид, который неспецифически связывается с молекулами ii класса лейкоцитарного антигена человека (hla)
EA200501206A1 (ru) Производные от сурвивина пептиды и их применение
DK0643726T3 (da) Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei
BR9911389A (pt) Composição de peptìdio como imunógeno para o tratamento de alergia
DE60030141D1 (de) Isolierte mhc-klasse ii-bindende peptide, und deren verwendung
DK0810870T3 (da) Isolerede, MAGE-2-afledte tumorafstødelsesantigenpræcurserpeptider og anvendelse heraf
CY1109179T1 (el) Ενα εκλεκτικο αντισωμα για υποδοχεα συνδετη που επαγει αποπτωση σχετιζομενη με παραγοντα νεκρωσης ογκων και χρησεις του
MY136095A (en) Use of human anti-ctla-4 antibodies for treatment of cancer
ATE494303T1 (de) An humane leukozytenantigen-(hla-)klasse-i- oder ii-moleküle bindende tumorassoziierte peptide und damit im zusammenhang stehender impfstoff gegen krebs
DE602005015990D1 (de) Immunogene t-helfer epitope von menschlichen tumorantigenen und deren verwendung in immunotherapeutischen methoden
DE69931482D1 (de) Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
WO2020185796A9 (en) High avidity wt1 t cell receptors and uses thereof
ATE405582T1 (de) P53 bindende t-zellrezeptormoleküle und deren verwendungen
ATE509025T1 (de) ßMIT MHC-KLASSE-I-PEPTIDEPITOPEN KOVALENT VERKN PFTES MEMBRANVERANKERTES BETA2-MIKROGLOBULINß
DK0996636T3 (da) HA-1-antigenet
ATE399176T1 (de) Nonapeptidische ny-eso-1 derivate und deren verwendung
NZ509417A (en) Novel peptides for use in immunotherapy of autoimmune diseases
WO2005058944A3 (en) Immunogenic peptides fragments of xage-1

Legal Events

Date Code Title Description
8364 No opposition during term of opposition